Home » Prices » NASDAQ:MGNX

MacroGenics, Inc. NASDAQ:MGNX

Today's live share price, quote history, chart & news

Price:
29.50 USD
Change:
+0.63 (2.18%)
Key Stats
Price open 29.45
Previous close 28.87
Market cap 1.45B
Volume 1.02M
Day high 30.58
Day low 28.7
Year high 30.58
Year low 4.04
Year to date change 175.84%
P/E Ratio -9.53
Company Profile
Fundamentals
Insider Information
News

About MacroGenics, Inc.

MacroGenics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer. 2. Its product pipeline includes Margetuximab, Flotetuzumab, Enoblituzumab, MGA012, MGD013, MGD019, MGD009, MGC018, and MGD007 for oncology; and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Company information

Company name
MacroGenics, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
384
CEO
Scott E. Koenig
Address
9704 Medical Center Drive, Rockville, MD, 20850-3368
Country
United States
Contact information
1.301.251.5172
Website
http://www.macrogenics.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.